000142641 001__ 142641
000142641 005__ 20240229105149.0
000142641 037__ $$aDKFZ-2019-00358
000142641 1001_ $$0P:(DE-He78)c1a5de00fb2617c5c43d8f30f6e0cd2b$$aDeumelandt, Katrin$$b0$$gfemale$$udkfz
000142641 245__ $$aDeterminants of response and resistance to glioma immunotherapy
000142641 260__ $$c2018
000142641 3367_ $$2DataCite$$aOutput Types/Dissertation
000142641 3367_ $$2ORCID$$aDISSERTATION
000142641 3367_ $$2BibTeX$$aPHDTHESIS
000142641 3367_ $$02$$2EndNote$$aThesis
000142641 3367_ $$0PUB:(DE-HGF)11$$2PUB:(DE-HGF)$$aDissertation / PhD Thesis$$bphd$$mphd$$s1550565051_28101
000142641 3367_ $$2DRIVER$$adoctoralThesis
000142641 502__ $$aDissertation, Universität Heidelberg, 2018$$bDissertation$$cUniversität Heidelberg$$gFakultät für Naturwissenschaften, Mathematik und Informatik
000142641 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000142641 909CO $$ooai:inrepo02.dkfz.de:142641$$pVDB
000142641 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c1a5de00fb2617c5c43d8f30f6e0cd2b$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000142641 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000142641 9141_ $$y2018
000142641 9201_ $$0I:(DE-He78)G160-20160331$$kG160$$lNeuroimmunologie und Hirntumorimmunologie$$x0
000142641 980__ $$aphd
000142641 980__ $$aVDB
000142641 980__ $$aI:(DE-He78)G160-20160331
000142641 980__ $$aUNRESTRICTED